Henry Schein stock heads into the open after a 1.0% daily loss

At the close on September 9, 2026, Henry Schein stock was reported at USD 87.97 after a 1.0% decline, with the move leaving the shares roughly 30.0% above their level one year earlier. Today, investors watch for further reactions to recent analyst target changes.

Henry Schein stock closed at USD 87.97 on Nasdaq on September 9, 2026, marking a daily loss of 1.00% versus the previous session, according to recent market data. The move left the shares about 30.0% higher than one year earlier, indicating a still solid twelve-month performance despite the latest setback.

September 9, 2026 in numbers

Henry Schein Inc. (ISIN US42548G1040, Nasdaq: HSIC) was quoted at a share price of USD 87.97 at the close of Nasdaq trading on September 9, 2026, with the session showing a 1.00% decline compared with the prior day based on data summarized by Nasdaq and CompaniesMarketCap. Per the same data overview, the company’s market capitalization around that close was about USD 9.80 billion, and the one-year change in the share price stood near 30.0% on a percent basis, underscoring that the stock remains well above its level of September 2025 even after the latest dip.

In the broader market environment, recent sessions saw major United States equity benchmarks come under pressure as higher oil prices and concerns about wholesale inflation reinforced expectations for sustained restrictive monetary policy. As Xinhua reported, the benchmark S&P 500 recently fell 0.58% and the Nasdaq Composite shed 0.65% in one session as higher oil prices and wholesale inflation figures bolstered rate-hike bets, a backdrop that can weigh on health care and medical distribution stocks such as Henry Schein when investors reassess valuation and growth expectations.

Analyst focus and market backdrop today

Today, Henry Schein heads into the open against continued scrutiny from analysts, with recent research updates adjusting target prices and valuation assumptions. According to an Argus quantitative report on Henry Schein, the current share price was cited near USD 87.30 and the firm raised its target price to USD 143.00 in commentary dated September 9, 2026, while a further note referenced target changes on September 10, 2026, indicating that the stock’s risk-reward profile remains actively debated in the analyst community as they digest the company’s latest operating trends and sector conditions.Yahoo Finance

Beyond stock-specific research, the broader market environment today is shaped by ongoing reactions to energy prices and inflation data, which have recently pressured major indices and can influence sentiment toward Henry Schein as a component of the health care and medical distribution space. As Xinhua highlighted, higher oil prices and stronger wholesale inflation readings have recently reinforced expectations for persistent monetary tightening, which in turn weighed on broad United States equity benchmarks and may continue to frame trading in Henry Schein stock today as investors gauge the implications for demand, costs, and valuation across the health care distribution sector.